6 active trials 5 recruiting 1 Phase 3 9 disease areas 1 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 115 → 122 locations
Kura Oncology, Inc.Phase 3 NCT07007312 Registry history of NCT07007312 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 4 | |
| Phase 1/2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07007312 | Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With… | Acute Myeloid Leukemia (AML) | Recruiting | 2026-10-07 |
| Phase 1/2 | ||||
| NCT04067336 | First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia | Advanced Malignant Neoplasm | Active, Not Recruiting | 2026-05-13 |
| Phase 1 | ||||
| NCT06001788 | Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory… | AML | Recruiting | 2026-08-20 |
| NCT06026410 | KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors | Solid Tumors With HRAS Alterations | Recruiting | 2026-06-08 |
| NCT05735184 | A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With… | Acute Myeloid Leukemia | Recruiting | 2026-03-13 |
| NCT06655246 | A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced… | Gastrointestinal Stromal Tumor (GIST) | Recruiting | 2026-02-05 |
Acute Myeloid Leukemia (AML) (4) · Leukemia (4) · Acute Lymphoblastic Leukemia (ALL) (1) · Colorectal Cancer (1) · Kidney Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Pancreatic Cancer (1) · Sarcoma (1)